Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Ibrutinib-Induced Cardiac Tamp...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Export Ready — 
Ibrutinib-Induced Cardiac Tamponade in Chronic Lymphocytic Leukemia

Ibrutinib-Induced Cardiac Tamponade in Chronic Lymphocytic Leukemia

Bibliographic Details
Main Authors: Keisuke Kidoguchi, Yasushi Kubota, Yuki Nishimura, Haruna Sano, Shinya Kimura
Format: Article
Language:English
Published: Galenos Publishing House 2021-02-01
Series:Turkish Journal of Hematology
Subjects:
ibrutinib
cardiac tamponade
bleeding
atrial fibrillation
cll
Online Access:https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjh&un=TJH-70607
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjh&un=TJH-70607

Similar Items

  • Successful treatment of “accelerated” chronic lymphocytic leukemia with single agent ibrutinib: A report of two cases.
    by: John Xie, et al.
    Published: (2021-01-01)
  • The Impact of Age on Survival in CLL Patients Receiving Ibrutinib as Initial Therapy
    by: Ujjani C, et al.
    Published: (2020-08-01)
  • Ibrutinib-Induced Skin Rash
    by: Sudhir Kirar, et al.
    Published: (2021-02-01)
  • Comparison of the blood immune repertoire with clinical features in chronic lymphocytic leukemia patients treated with chemoimmunotherapy or ibrutinib
    by: Baustin M. Welch, et al.
    Published: (2023-12-01)
  • Ibrutinib dose modifications in the management of CLL
    by: Camille Hardy-Abeloos, et al.
    Published: (2020-06-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs